Scheithauer W - Search Results

1

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.

Scheithauer W, Putora PM, Grünberger B, Eisterer W, Wöll E, Prager G, Schaberl-Moser R, Greil R, Glatzer M. Scheithauer W, et al. Therap Adv Gastroenterol. 2019 Sep 23;12:1756284819877635. doi: 10.1177/1756284819877635. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31579123 Free PMC article.

2

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer.

Prager GW, Braemswig KH, Martel A, Unseld M, Heinze G, Brodowicz T, Scheithauer W, Kornek G, Zielinski CC. Prager GW, et al. Among authors: scheithauer w. Cancer Sci. 2014 Aug;105(8):996-1001. doi: 10.1111/cas.12451. Epub 2014 Jul 31. Cancer Sci. 2014. PMID: 24850362 Free PMC article.

3

Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma.

Scheithauer W, Kornek G, Prager G, Stranzl N, Laengle F, Schindl M, Friedl J, Klech J, Roethlin S, Zielinski C. Scheithauer W, et al. J Gastrointest Oncol. 2016 Apr;7(2):234-8. doi: 10.3978/j.issn.2078-6891.2015.107. J Gastrointest Oncol. 2016. PMID: 27034791 Free PMC article.

4

Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma.

Unseld M, Scheithauer W, Weigl R, Kornek G, Stranzl N, Bianconi D, Brunauer G, Steger G, Zielinski CC, Prager GW. Unseld M, et al. Among authors: scheithauer w. J Gastrointest Oncol. 2016 Aug;7(4):588-94. doi: 10.21037/jgo.2016.05.01. J Gastrointest Oncol. 2016. PMID: 27563449 Free PMC article.

5

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease.

Kieler M, Scheithauer W, Zielinski CC, Chott A, Al-Mukhtar A, Prager G. Kieler M, et al. Among authors: scheithauer w. ESMO Open. 2016 Dec 15;1(6):e000084. doi: 10.1136/esmoopen-2016-000084. eCollection 2016. ESMO Open. 2016. PMID: 28255450 Free PMC article.

6

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel.

Bianconi D, Heller G, Spies D, Herac M, Gleiss A, Liebmann-Reindl S, Unseld M, Kieler M, Scheithauer W, Streubel B, Zielinski CC, Prager GW. Bianconi D, et al. Among authors: scheithauer w. Sci Rep. 2017 Jul 7;7(1):4851. doi: 10.1038/s41598-017-04743-0. Sci Rep. 2017. PMID: 28687745 Free PMC article.

7

Regorafenib therapy in metastatic colorectal cancer patients: markers and outcome in an actual clinical setting.

Unseld M, Filip M, Seirl S, Gleiss A, Bianconi D, Kieler M, Demyanets S, Scheithauer W, Zielinski C, Prager G. Unseld M, et al. Among authors: scheithauer w. Neoplasma. 2018;65(4):599-603. doi: 10.4149/neo_2018_170727N506. Neoplasma. 2018. PMID: 29940763

8

Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.

Unseld M, Drimmel M, Siebenhüner A, Gleiss A, Bianconi D, Kieler M, Scheithauer W, Winder T, Prager GW. Unseld M, et al. Among authors: scheithauer w. Clin Colorectal Cancer. 2018 Dec;17(4):274-279. doi: 10.1016/j.clcc.2018.05.012. Epub 2018 Jun 8. Clin Colorectal Cancer. 2018. PMID: 30042010

9

Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores.

Gargiulo P, Dietrich D, Herrmann R, Bodoky G, Ruhstaller T, Scheithauer W, Glimelius B, Berardi S, Pignata S, Brauchli P. Gargiulo P, et al. Among authors: scheithauer w. Ther Adv Med Oncol. 2019 Jan 2;11:1758835918818351. doi: 10.1177/1758835918818351. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30636977 Free PMC article.

10

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.

Kieler M, Unseld M, Bianconi D, Scheithauer W, Prager GW. Kieler M, et al. Among authors: scheithauer w. Ther Adv Med Oncol. 2019 Jul 17;11:1758835919853196. doi: 10.1177/1758835919853196. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31360237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page